Monopar Therapeutics Inc.
USD92.59
-1.97 (-2.08%)
CEO
Chandler D. Robinson
IPO Date
2019-12-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$96.41
Prev. Close
$94.56
Day Low
$91.90
Day High
$97.98
52W Low
$29.18
52W High
$105.00
Market Cap
$0.62B
Volume
0.11M
| -16.2 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -150.4% | -114.4% | 0.00 | 4.17 | -2.9 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -104.2% | -79.5% | 0.00 | 4.21 | -14.3 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -48.1% | -44.4% | 0.00 | 12.98 | -22.0 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -40.2% | -37.4% | 0.00 | 14.28 | -53.2 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -33.5% | -31.6% | 0.00 | 18.27 | -208.0 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -46.7% | -44.1% | 0.00 | 18.32 | -427.8 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -172.1% | -166.7% | 0.00 | 29.28 | -83.4 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -41.9% | -40.9% | 0.00 | 32.48 | -1101.4 |
| -21.0 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -2.4% | -2.4% | 0.00 | 56.10 | -42.3 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -4.7% | -4.6% | 0.00 | 33.94 | -25.5 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -4.9% | -4.8% | 0.00 | 36.92 | -24.0 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -19.9% | -18.1% | 0.00 | 11.47 | -5.8 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -26.4% | -21.5% | 0.00 | 5.41 | -14.8 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -28.2% | -23.9% | 0.00 | 6.59 | -6.2 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -21.9% | -18.4% | 0.00 | 6.21 | -8.3 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -32.5% | -24.7% | 0.00 | 4.17 | -3.5 |